Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche

Showing 15 posts of 710 posts found.

MHRA accepts Roche’s Tecentriq into Early Access to Medicines scheme

January 25, 2017
Research and Development, Sales and Marketing MHRA, Roche, eams, tecentriq

Roche’s Tecentriq (atezolizumab) has scored another positive opinion, this time from the Medicines and Healthcare products Regulatory Agency (MHRA), which …

News
roche_close

Roche’s Actemra granted Priority Review by FDA

January 24, 2017
Manufacturing and Production, Sales and Marketing Actemra, FDA, Roche, priority review

Roche’s drug, Actemra (also known as RoActemra in Europe), has been granted priority review designation by the FDA for the …

News
access_accelerated

22 pharma companies join forces for global non-communicable disease initiative

January 18, 2017
Research and Development BMS, Celgene, Eisai, Eli Lilly, GSK, J&J, JJ, MSD, Merck, Novartis, Pfizer, Roche, Sanofi, Takeda

The World Economic Forum Annual Meeting in Switzerland has seen the launch of Access Accelerated, a global initiative consisting of …

News
merck_and_co

MSD looks to jump the gun with combination immunotherapy application

January 11, 2017
Research and Development, Sales and Marketing AstraZeneca, BMS, MSD, Roche, immunotherapy, keytruda

MSD, known as Merck in North America, has launched a bold move by filing Keytruda, and being accepted, for Priority …

News
roche

Roche’s Tecentriq scores another bladder cancer Priority Review

January 9, 2017
Sales and Marketing Roche, bladder cancer, tecentriq

Roche has announced that its immunotherapy drug Tecenetriq (atezolizumab) has been awarded Priority Review by the FDA for the treatment …

News
peter_schurrenberger

Insider interview: Roche discusses the importance of sustainability in pharma manufacturing

January 6, 2017
Manufacturing and Production, Medical Communications Roche

Peter Schurrenberger, Chief Safety, Health and Environment Officer at Roche, discusses their recent recognition as a leader for corporate action …

News
roche__tree

Roche’s ground-breaking MS drug delayed by manufacturing issues

December 22, 2016
Genentech, MS, Roche, multiple sclerosis

Roche has released both good and bad news just before Christmas. The good news is very good news for individuals …

News
bill_anderson

Genentech announces Bill Anderson as new CEO

December 16, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bill Anderson, Genentech, Roche

Genentech, the biotech subsidiary of Roche, has announced that Genentech veteran, Ian Clark, will retire as CEO on 1 January. …

Appointment
shutterstock_311949818

Neurodegenerative market to be worth $45 billion by 2022

December 12, 2016
Sales and Marketing Biogen, GBI Research, Novartis, Roche, Sanofi, neurodegenerative

Neurodegenerative disorders including Alzheimer’s, Parkinson’s, Huntington’s, amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) form a lucrative worldwide market which …

News

First generic copy of Roche’s Tamiflu hits US market

December 12, 2016
Sales and Marketing Alvogen, Roche, Tamiflu

Drugmaker Alvogen has released the first generic version of Roche’s flu medication Tamiflu (oseltamivir) in the US, where it expects …

News
merck_kapa_biosystems

Merck and Roche extend distribution ties

December 5, 2016
Manufacturing and Production Merck, Roche, distribution

Merck KGaA and Roche have announced that they will further increase the distribution links between the two companies by having …

News
roche_florence_sc_site

Patheon acquires state-of-the-art manufacturing facility from Roche

November 28, 2016
Manufacturing and Production Patheon, Roche, South Carolina

Patheon, a provider of drug development and delivery to the pharmaceutical and biopharma sectors, announced that it has acquired a …

News
deb_lancaster

Insider interview: Roche discusses efficacy of CDF and NICE

November 25, 2016
Medical Communications, Sales and Marketing CDF, NICE, Roche

Deborah Lancaster, Head of Market Access at Roche, discusses, in the latest issue of Pharmafile, the efficacy of the National …

News
images

NICE approves Roche’s Perjeta for breast cancer

November 16, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, Perjeta, Roche, breast cancer

NICE has announced its approval of Roche’s Perjeta (pertuzumab) as a neoadjuvant treatment of HER2-positive, locally advanced, inflammatory or early-stage …

News
germany-flag-flying-german-breeze-flag-pole-waving-1398668

Roche, Bayer and more speak out against German pricing cap plans

November 14, 2016
Sales and Marketing Bayer, Germany, Roche

A number of major drug manufacturers have spoken out against German government plans to cap prescription drug pricing in the …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025